Anbio Biotechnology (NNNN)
Anbio Biotechnology will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.00 - $6.00
Shares Offered
1,600,000
Deal Size
$8.80M
Anbio Biotechnology Statistics
Total Valuation
NNNN has a market cap or net worth of $241.40 million. The enterprise value is $231.09 million.
Market Cap | 241.40M |
Enterprise Value | 231.09M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NNNN has 43.89 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 43.89M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 55.75.
PE Ratio | 55.75 |
Forward PE | n/a |
PS Ratio | 25.41 |
Forward PS | n/a |
PB Ratio | 13.11 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 53.37 |
EV / Sales | 24.32 |
EV / EBITDA | 57.11 |
EV / EBIT | 57.15 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | 28.28 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -14.12 |
Financial Efficiency
Return on equity (ROE) is 23.51% and return on invested capital (ROIC) is 22.47%.
Return on Equity (ROE) | 23.51% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 22.47% |
Revenue Per Employee | $351,928 |
Profits Per Employee | $160,360 |
Employee Count | 27 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NNNN had revenue of $9.50 million and earned $4.33 million in profits. Earnings per share was $0.10.
Revenue | 9.50M |
Gross Profit | 5.47M |
Operating Income | 4.14M |
Pretax Income | 4.33M |
Net Income | 4.33M |
EBITDA | 4.05M |
EBIT | 4.04M |
Earnings Per Share (EPS) | $0.10 |
Balance Sheet
Cash & Cash Equivalents | 10.31M |
Total Debt | n/a |
Net Cash | 10.31M |
Net Cash Per Share | $0.23 |
Equity (Book Value) | 18.42M |
Book Value Per Share | 0.42 |
Working Capital | 18.24M |
Cash Flow
Operating Cash Flow | -634,089 |
Capital Expenditures | n/a |
Free Cash Flow | -634,089 |
FCF Per Share | -$0.01 |
Margins
Gross margin is 57.61%, with operating and profit margins of 43.55% and 45.57%.
Gross Margin | 57.61% |
Operating Margin | 43.55% |
Pretax Margin | 45.57% |
Profit Margin | 45.57% |
EBITDA Margin | 42.59% |
EBIT Margin | 42.55% |
FCF Margin | -6.67% |
Dividends & Yields
NNNN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 1.79% |
FCF Yield | -0.26% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |